Moderator: Evandro Fei Fang
09:00-09:05: Welcome speech by Dr. Helge Røsjø (Research Director at Ahus, UiO)
09:05-09:50: Key note Dr. Charles Brenner: NAD, nicotinamide riboside supplementation and ageing (The University of Iowa)
09:50-10:10: Dr. Hilde Nilsen: NAD+ in DNA repair and Ataxia Telangiectasia (Ahus, UiO)
10:10-10:30: Dr. Mathias Ziegler: Dynamics, interactions and functional roles of subcellular NAD+ pools (UiB).
10:30-10:50: Two short talks from postdocs: Dr. Sofie Lautrup: NAD+ in longevity and stem cell rejuvenation (Ahus, UiO) and Dr. Yahyah Aman: NAD+ in neuronal resilience and Alzheimer`s disease (Ahus, UiO)
10:50-11:10 Coffee and networking
Moderator: Hilde Nilsen
11:10-11:30: Dr. Ole-Bjørn Tysnes: ‘NAD+ and amyotrophic lateral sclerosis /ALS’ (UiB & HUH)
11:30-11:50: Dr. Charalampos Haris Tzoulis: ‘NO-PARK: a trial of nicotinamide riboside in Parkinson’s disease?’ (UiB & HUH)
11:50-12:10: Dr. Torbjørn Omland: ‘NAD+ as a potential cardio-protective agent in the cardio-oncology’ (Ahus, UiO)
12:10-12:30: Dr. Arne Vasli Lund Søraas: ‘NR clinical trial in an age-related disease’ (OUS, UiO)
Moderator: Trygve Holmøy
12:30-13:00: Round Table discussion on ‘Opportunities and challenges in NR-based clinical trials’ (UiO)
13:10-14:00: Lunch for invited speakers and staff at the Akershus University Hospital canteen (2nd floor)
Please contact Dr. Evandro F. Fang for any further queries.
University of Oslo (UiO), Akershus University Hospital (Ahus), Oslo universitetssykehus (OUS), University of Bergen (UiB) and Haukeland University Hospital (HUH).